ArticleScientific reports2025
Effective skin cancer classification by modified and optimized inception-ResNet-V2 model.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CBAM-Xception: An Attention-Guided Framework for Skin Cancer Classification.Journal of imaging informatics in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial Intelligence tools are flourishing in biomedical diagnosis, particularly in oncology. The prediction of skin cancer from dermoscopic images using deep learning neural networks has gained importance in recent years because of their inherent early non-invasive diagnostic capabilities. This study presents the results of the classification of benign nevus and malignant melanoma lesions using a deep learning model. The model incorporates an efficient pre-processing stage powered by median filtering and a class-balancing stage powered by the Synthetic Minority Oversampling Technique (SMOTE) to improve classification results. First, the classification efficiency of four pre-trained models, namely, ResNet50, EfficientNet B0, Inception-V3, and Inception-ResNet-V2, were studied, and the results revealed that they achieved accuracies of 93.90%, 94.37%, 94.87%, and 95.77%, respectively. Second, the effect of optimization and hyperparameter tuning on the Inception-ResNet-V2 model is studied considering Adam, Nadam, and AdaMax optimizers, with fivefold cross validation. The experimental results revealed that the AdaMax optimizer with validation achieved an overall consistent performance with accuracy, sensitivity, and specificity of 97.65%, 96.67%, and 98.92%, respectively. The results support the efficacy of the model in predicting skin cancer malignancy; thus, its integration into clinical practice could benefit healthcare services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.